Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Canadian scientists have identified a promising therapeutic target to attack to prevent breast cancer from recurring: the ...